Ning Yang
5 Papers
Ning Yang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study
Houxu Ning,Hao Zhou,Jing Ren,Gaiyan Zhou,Ning Yang,Zhenfu Wang,Can-Xing Yuan,Zuojun Tian,Ju-ping Chen,Lihua Shen,Hui-Fen Zheng,Yang Zhao,Haidong Wang,Weiguo Liu,Zhifeng Liu +14 more
TL;DR: Zishen Pingchan granule (ZPG) is a traditional Chinese herbal recipe for treating Parkinson's disease (PD), which is usually used as an add-on drug with some antiparkinsonian drugs in China as mentioned in this paper .
Effect of Gushen shetuo decoction in improving motor and non-motor symptoms and the expression of PERK, ATF4 and CHOP in patients with Parkinson's disease.
Peishan Li,Ning Yang,Weifeng Guo,Houxu Ning,Wenhao Cheng,Haidong Wang +5 more
TL;DR: It is confirmed that Gushen Shetuo decoction effectively improved the drooling of patients with PD and showed high safety.
1
Potential Mechanisms of Shu Gan Jie Yu Capsule in the Treatment of Mild to Moderate Depression Based on Systemic Pharmacology and Current Evidence
TL;DR: Wang et al. as mentioned in this paper used traditional Chinese medicine database and analysis platform (TCMSP), the Encyclopedia of Traditional Chinese Medicine (ETCM), and Swiss Target Prediction servers to screen and predict the bioactive components of the SGJY capsule and their antidepressive targets.
Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease
TL;DR: The prevalence and affective correlates of SCD in de novo PD patients are determined and subjective cognitive impairment without concurrent objective cognitive deficits is referred to.
Effect of Zishen pingchan granules combined with pramipexole on serum BDNF, IL-1β, IL-6, CRP, TNF-α levels in depressed patients with Parkinson's disease: Results of a randomized, double-blind, controlled study
Houxu Ning,Hao Zhou,Ning Yang,Jing Ren,Haidong Wang,Weiguo Liu,Yang Zhao +6 more
TL;DR: ZPG may potentially ameliorate depressive symptoms in PD patients, with the potential mechanism involving mitigation of reductions in serum BDNF level and an increase in IL-6 level.